DAVID T. PURTILO, M.D.; JANET HAMILTON
This content is PDF only. Please click on the PDF icon to access.
To the editor: The X-Linked Lymphoproliferative Syndrome Registry was recently established and is funded by the National Cancer Institute. We invite referrals of possible cases of the X-linked lymphoproliferative syndrome as well as unusual complications associated with infectious mononucleosis. The following criteria may be used to ascertain whether a patient is a candidate for the registry.
1. Phenotypes (1) of the proliferative types including fatal infectious mononucleosis, immunoblastic sarcoma of B cells, immunodeficiency with hyper IgM after infectious mononucleosis, or American Burkitt lymphoma. Aproliferative phenotypes such as agranulocytosis, aplastic anemia, or acquired hypogammaglobulinemia.
2. The phenotypes of X-linked lymphoproliferative syndrome
PURTILO DT, HAMILTON J. X-Linked Lymphoproliferative Syndrome Registry. Ann Intern Med. 1979;90:995. doi: 10.7326/0003-4819-90-6-995_2
Download citation file:
Published: Ann Intern Med. 1979;90(6):995.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use